NO975862L - P-selektinligander og relaterte molekyler og fremgangsmåter - Google Patents

P-selektinligander og relaterte molekyler og fremgangsmåter

Info

Publication number
NO975862L
NO975862L NO975862A NO975862A NO975862L NO 975862 L NO975862 L NO 975862L NO 975862 A NO975862 A NO 975862A NO 975862 A NO975862 A NO 975862A NO 975862 L NO975862 L NO 975862L
Authority
NO
Norway
Prior art keywords
methods
ligands
determinant
selectin ligands
related molecules
Prior art date
Application number
NO975862A
Other languages
English (en)
Norwegian (no)
Other versions
NO975862D0 (no
Inventor
Brian Seed
Tara Pouyani
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Publication of NO975862D0 publication Critical patent/NO975862D0/no
Publication of NO975862L publication Critical patent/NO975862L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4727—Mucins, e.g. human intestinal mucin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/473—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used alpha-Glycoproteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
NO975862A 1995-06-14 1997-12-12 P-selektinligander og relaterte molekyler og fremgangsmåter NO975862L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21395P 1995-06-14 1995-06-14
PCT/US1996/010043 WO1997000079A1 (en) 1995-06-14 1996-06-11 P-selectin ligands and related molecules and methods

Publications (2)

Publication Number Publication Date
NO975862D0 NO975862D0 (no) 1997-12-12
NO975862L true NO975862L (no) 1998-02-12

Family

ID=21690430

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975862A NO975862L (no) 1995-06-14 1997-12-12 P-selektinligander og relaterte molekyler og fremgangsmåter

Country Status (14)

Country Link
EP (1) EP0833650A4 (cs)
JP (1) JPH11508131A (cs)
KR (1) KR19990022954A (cs)
AR (1) AR003436A1 (cs)
AU (1) AU6272996A (cs)
BR (1) BR9608918A (cs)
CA (1) CA2224625A1 (cs)
CZ (1) CZ401497A3 (cs)
HU (1) HUP9901131A2 (cs)
IL (1) IL122590A0 (cs)
NO (1) NO975862L (cs)
TR (1) TR199701620T1 (cs)
WO (1) WO1997000079A1 (cs)
ZA (1) ZA965032B (cs)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999043834A2 (en) * 1998-02-27 1999-09-02 Genetics Institute, Inc. P-selectin ligand protein, including tetrameric fusion proteins
MXPA03005945A (es) * 2000-12-29 2004-10-15 Savient Pharmaceuticals Inc Moleculas aisladas que comprenden epitopes que contienen grupos sulfato, anticuerpos para tales epitopes y usos de ellos.
JP4599027B2 (ja) * 2002-10-30 2010-12-15 東洋水産株式会社 Ｌ−セレクチン結合阻害剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0544815A1 (en) * 1990-07-17 1993-06-09 The Board Of Regents Of The University Of Oklahoma Peptides from the GMP-140 lectinbindingdomain and selectin binding ligands on carbonhydrates
US5318890A (en) * 1991-05-06 1994-06-07 The Regents Of The University Of California Assays for inhibitors of leukocyte adhesion
AU681369B2 (en) * 1992-11-16 1997-08-28 Board Of Regents Of The University Of Oklahoma, The Glycoprotein ligand for P-selectin and methods of use thereof
WO1995030001A2 (en) * 1994-04-28 1995-11-09 Genetics Institute, Inc. Novel p-selectin ligand protein

Also Published As

Publication number Publication date
AR003436A1 (es) 1998-08-05
CZ401497A3 (cs) 1998-07-15
IL122590A0 (en) 1998-06-15
ZA965032B (en) 1997-03-14
CA2224625A1 (en) 1997-01-03
AU6272996A (en) 1997-01-15
KR19990022954A (ko) 1999-03-25
TR199701620T1 (xx) 1998-05-21
EP0833650A1 (en) 1998-04-08
JPH11508131A (ja) 1999-07-21
NO975862D0 (no) 1997-12-12
BR9608918A (pt) 1999-06-15
EP0833650A4 (en) 2005-01-19
WO1997000079A1 (en) 1997-01-03
HUP9901131A2 (hu) 1999-07-28

Similar Documents

Publication Publication Date Title
Parham et al. Carbohydrate moeity of HLA antigens. Antigenic properties and amino acid sequences around the site of glycosylation
Feinstein et al. Conformation of the free and antigen-bound IgM antibody molecules
Berndt et al. Purification and preliminary physicochemical characterization of human platelet membrane glycoprotein V.
Perutz Nature of haem–haem interaction
Benesch et al. The interaction of hemoglobin and its subunits with 2, 3-diphosphoglycerate.
Marder et al. High Molecular Weight Derivatives of Human Fibrinogen Produced by Plasmin: III. THEIR NH2-TERMINAL AMINO ACIDS AND COMPARISON WITH THE “NH2-TERMINAL DISULFIDE KNOT
Kassis et al. Mechanism of action of cholera toxin on intact cells. Generation of A1 peptide and activation of adenylate cyclase.
DK0710228T3 (da) Hydraziner med N3S-konfiguration som radionuclidchelatorer
NO20051950L (no) Konjugater av et polypeptid og en biokompatibel polymer
AU2387088A (en) Cationized antibodies for delivery through the blood-brain barrier
DE69434384D1 (de) Metalkomplexbildner
Reid et al. Structural relationships between human erythrocyte sialoglycoproteins β and γ and abnormal sialoglycoproteins found in certain rare human erythrocyte variants lacking the Gerbich blood-group antigen (s)
DK0413188T3 (da) Fremgangsmåde til fremstilling af umodificerede, intravenøst administrerbare IgM- og/eller IgA-holdige immunglobulinpræparater
ATE158082T1 (de) Bestimmung von peptidmotiven auf mhc-molekülen
AU5492786A (en) Boronic acid adducts of technetium-99m doxime complexes
Ronda et al. High-and low-affinity PEGylated hemoglobin-based oxygen carriers: Differential oxidative stress in a Guinea pig transfusion model
NO975862L (no) P-selektinligander og relaterte molekyler og fremgangsmåter
SE8301795L (sv) Plasminogenaktivatorkomplex
EP0393895A3 (en) Silicometallate molecular sieves and their use as catalysts in oxidation of alkanes
Sha’Afi et al. Membrane water channels and SH-groups
DE3773077D1 (de) Immunotoxine, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
Kavanaugh et al. Affinity labeling of hemoglobin with 4, 4'-diisothiocyanostilbene-2, 2'-disulfonate: covalent cross-linking in the 2, 3-diphosphoglycerate binding site
Guillochon et al. Studies on haemoglobin immobilized by cross-linking with glutaraldehyde cross-lInked soluble polymers and artificial membranes
Parkhurst et al. Kinetics of the reaction of hybrid-heme hemoglobins with carbon monoxide
MX9710114A (es) Ligandos de p-selectina y moleculas y metodos relacionados.